TY - JOUR AU - Gopalakrishna, G. AU - Langendam, Miranda W. AU - Scholten, Rob J. P. M. AU - Bossuyt, Patrick M. M. AU - Leeflang, Mariska M. G. PY - 2016 DA - 2016/11/10 TI - Defining the clinical pathway in cochrane diagnostic test accuracy reviews JO - BMC Medical Research Methodology SP - 153 VL - 16 IS - 1 AB - The value of a medical test depends on the context in which it might be used. Ideally, questions, results and conclusions of a diagnostic test accuracy (DTA) systematic review should be presented in light of this context. There is increasing acceptance of the value for knowing the impact a test can have on downstream consequences such as costs, implications for further testing and treatment options however there is currently no explicit guidance on how to address this. Authors of a Cochrane diagnostic review have recently been asked to include the clinical pathway in which a test maybe used. We aimed to evaluate how authors were developing their clinical pathways in the light of this. SN - 1471-2288 UR - https://doi.org/10.1186/s12874-016-0252-x DO - 10.1186/s12874-016-0252-x ID - Gopalakrishna2016 ER -